发明名称 TRICYCLIC BENZAZEPINE VASOPRESSIN ANTAGONISTS
摘要 1. Tricyclic benzazepine of the general formula: wherein Y is a moiety selected from -(CH2)n- wherein n is an integer from 0 to 2, alkyl(C1-C3) and A-B is a moiety selected from and wherein m is an integer from 1 to 2 provided that when Y is -(CH2)n- and n is 2, m may also be zero and when n is zero, m may also be three, provided also that when Y is -(CH2)n- and n is 2, m may not be two; and the moiety: represents: (1) phenyl or substituted phenyl optionally substituted by one or two substituents selected from (C1-C3)alkyl, halogen, amino, (C1-C3)alkoxy or (C1-C3)alkylamino; (2) a 5-membered aromatic (unsaturated) heterocyclic ring having one heteroatom selected from O, N or S; (3) a 6-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom; (4) a 5- or 6-membered aromatic (unsaturated) heterocyclic ring having two nitrogen atoms; (5) a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom together with either one oxygen atom or one sulfur atom; wherein the 5- or 6-membered heterocyclic rings are optionally substituted by (C1-C3)alkyl, halogen or (C1-C3)alkoxy; the moiety: is a five membered aromatic (unsaturated) nitrogen containing heterocyclic ring wherein D, E and F are selected from carbon and nitrogen and wherein the carbon atoms may be optionally substituted by substituents, selected from halogen, (C1-C3)alkyl, hydroxy, -COCl3, -COCF3, , alkyl (C1-C3), , -CHO, amino, (C1-C3) alkoxy, (C1-C3) alkylamino, CONH-alkyl(C1-C3), and CON-[alkyl(C1-C3)]2; q is one or two; Rb is independently selected from hydrogen, -CH3 or C2H5; R<3> is a moiety of the formula: wherein Ar is a moiety selected from the group consisting of R<4> is selected from hydrogen, alkyl(C1-C3); -COalkyl(C1-C3); R<1> and R<2> are independently selected from hydrogen, (C1-C3) alkyl, (C1-C3)alkoxy and halogen; R<5> is selected from hydrogen, (C1-C3) alkyl, (C1-C3) alkoxy and halogen; R<6> is selected from (a) moieties of the formulas: alkyl(C3-C8) straight or branched, alkyl (C3-C8) straight or branched, -NHSO2-alkyl (C3-C8) straight or branched, alkenyl(C3-C8) straight or branched, alkenyl(C3-C8) straight or branched, -NHSO2-alkenyl(C3-C8) straight or branched, wherein cycloalkyl is defined as C3-C6cycloalkyl, cyclohexyl or cyclopentenyl; Ra is independently selected from hydrogen, -CH3, -C2H5, -(CH2)q-O-alkyl(C1-C3) and -CH2CH2OH, q is one or two, and R1, R2 and Rb are as hereinbefore defined; (b) moieties of the formula: wherein R<7> is alkyl(C3-C8), alkenyl(C3-C8), -(CH2)p-cycloalkyl (C3-C6), wherein p is one to five and X is selected from O, S, NH, NCH3; wherein R<1> and R<2> are as hereinbefore defined; (c) a moiety of the formula: wherein J is Ra, alkyl(C3-C8) branched or unbranched, alkenyl (C3-C8) branched or unbranched, O-alkyl (C3-C8) branched or unbranched, -O-alkenyl (C3-C8) branched or unbranched, tetrahydrofuran, tetrahydrothiophene, the moieties: or -CH2-K', wherein K' is (C1-C3)alkoxy, halogen, tetrahydrofuran, tetrahydrothiophene or the heterocyclic ring moiety: wherein D, E, F and G are selected from carbon or nitrogen and wherein the carbon atoms may be optionally substituted with halogen, (C1-C3)alkyl, hydroxy, -CO-alkyl(C1-C3), CHO, (C1-C3)alkoxy, -CO2-alkyl(C1-C3), and Ra and Rb are as hereinbefore defined; (d) a moiety of the formula: wherein Rc is selected from halogen, (C1-C3) alkyl, -O-alkyl (C1-C3), OH, alkyl (C1-C3), -S-alkyl (C1-C3), wherein Ra and Rb are as hereinbefore defined, and Ar' is selected from moieties of the formula: wherein W' is selected from O, S, NH, N-alkyl(C1-C3), NHCO-alkyl(C1-C3), and NSO2 alkyl(C1-C3); R8 and R9 are independently selected from hydrogen, alkyl(C1-C3), -S-alkyl(C1-C3), halogen, -NH-alkyl(C1-C3), -N-[alkyl(C1-C3)]2, -OCF3, -OH, -CN, -S-CF3, -NO2, -NH2, O-alkyl(C1-C3), -N(Rb)(CH2)vN(Rb)2, and CF3 wherein v is one to three and; R<10> is selected from hydrogen, halogen and alkyl(C1-C3); R<14> is -O-alkyl (C1-C3) branched or unbranched, -NH-alkyl (C3- C8) branched or unbranched, wherein n is O or 1; Ra is hydrogen, -CH3 or -C2H5; R' is hydrogen, (C1-C3)alkyl, (C1-C3)alkoxy or halogen; R<20> is hydrogen, halogen, (C1-C3) alkyl, (C1-C3) alkoxy, NH2, -NH-(C1-C3) alkyl, -N-[(C1-C3)alkyl]2, and the pharmaceutically acceptable salts thereof. 2. A compound according to Claim 1 wherein R<3> is the moiety: and Ar is selected from the moiety: wherein R<6> is selected from the moieties of the formulas: wherein R<1>, R<2>, R<7>, R<14>, Ra, Rb, X and Ar are as defined in Claim 1. 3. A compound according to Claim 1 wherein R<3> is the moiety: and Ar is selected from the moiety: wherein R<6> is selected from the moieties of the formulas: wherein R<1>, R<2>, Ra and Rb, R<7>, R<14>, X and cycloalkyl are as defined in Claim 1 and Ar' is selected from the moieties: wherein R<5>, R<8>, R<9> and W' are as defined in Claim 1. 4. A compound according to Claim 1 wherein Y is -(CH2)n- and n is zero or one; A-B is or wherein R<3> is a moiety of the formula: wherein Ar, R<1>, R<2>, R<4>, R<5>, R<6>, R<7>, R<8>, R<9>, R<10> and R<14> are as defined in Claim 1 and m is an integer from 1-2. 5. A compound according to Claim 1 wherein Y is -(CH2)n- and n is one; A-B is or R<3> is the moiety of the formula: Ar is the moiety: R<6> is selected from (a) moieties of the formulas: alkyl (C3- C8) straight or branched, alkyl(C3-C8) straight or branched, -NHSO2-alkyl(C3-C8) straight or branched, alkenyl(C3-C8) straight or branched, alkenyl(C3-C8) straight or branched, - NHSO2-alkenyl (C3- C8) straight or branched, wherein cycloalkyl is defined as C3-C6 cycloalkyl, cyclohexenyl, or cyclopentenyl; Ra is independently selected from hydrogen, -CH3, -C2H5, -(CH2)q-O-alkyl(C1-C3), -CH2CH2OH; q is one or two; Rb is independently selected from hydrogen, -CH3, and -C2H5; or (b) a moiety of the formula: wherein J is Ra, alkyl(C3-C8) branched or unbranched, alkenyl(C3-C8) branched or unbranched, O-alkyl(C3-C8) branched or unbranched, -O-alkenyl(C3-C8) branched or unbranched, tetrahydrofuran, tetrahydrothiophene, the moieties: or -CH2-K', wherein K' is (C1-C3)alkoxy, halogen, tetrahydrofuran, tetrahydrothiophene or the heterocyclic ring moiety: wherein D, E, F and G are selected from carbon or nitrogen and wherein the carbon atoms may be optionally substituted with halogen, (C1-C3)alkyl, hydroxy, -CO-alkyl (C1-C3), CHO, (C1-C2)alkoxy, -CO2-alkyl(C1-C3), and Ra, Rb and R<8> are as herein-before defined; (c) a moiety of the formula: wherein Rc is selected from halogen, (C1-C3)alkyl, -O-alkyl (C1- C3), OH, wherein Ra, Rb are as hereinbefore defined; Ar' is wherein R<1>, R<2>, R<5>, R<7>, R<8>, R<9>, R<14>, and X are as previously defined in Claim 1. 6. A compound according to Claim 1 wherein Y is -(CH2)n- and n is zero or one; the moiety: is a phenyl ring optionally substituted with one or two substituents selected from (C1-C3)alkyl, halogen, amino, (C1-C3)alkoxy and (C1-C3)alkylamino, or a thiophene, furan, pyrrole or pyridine ring; A-B is or m is one, when n is one, and m is one or two when n is zero; R<3> is the moiety of the formula: wherein Ar is the moiety: R<6> is selected from (a) moieties of the formulas: alkyl(C3-C8) straight or branched, alkyl (C3-C8) straight or branched, - NHSO2-alkyl (C3-C8) straight or branched, alkenyl(C3-C8) straight or branched, alkenyl (C3-C8) straight or branched, - NHSO2-alkenyl (C3-C8) straight or branched, wherein cycloalkyl is defined as C3-C6 cycloalkyl, cyclohexyl or cyclopentenyl; Ra is independently selected from hydrogen, -CH3, -C2H5, -(CH2)qO-alkyl(C1-C3), -CH2CH2OH; q is one or two; Rb is independently selected from hydrogen, -CH3, and -C2H5; or (b) a moiety of the formula: wherein J is Ra, alkyl(C3-C8) branched or unbranched, alkenyl(C3-C8) branched or unbranched, O-alkyl(C3-C8) branched or unbranched, O-alkenyl(C3-C8) branched or unbranched, tetrahydrofuran, tetrahydrothiophene, the moieties: or -CH2-K', wherein K' is (C1-C3)alkoxy, halogen, tetrahydrofuran, tetrahydrothiophene or the heterocyclic ring moiety: wherein D, E, F and G are selected from carbon or nitrogen and wherein the carbon atoms may be optionally substituted with halogen, (C1-C3)alkyl, hydroxy, -CO-alkyl(C1-C3), CHO, (C1-C3)alkoxy, -CO2-alkyl(C1-C3), and Ra and Rb are as hereinbefore defined; (c) a moiety of the formula: wherein Rc is selected from halogen, (C1-C3) alkyl, -O-alkyl (C1- C3), OH, alkyl (C1-C3), -S-alkyl(C1-C3), wherein Ra and Rb are as hereinbefore defined; Ar' is selected from the group wherein D, E, F, Ra, Rb, R<1>, R<2>, R<4>, R<5>, R<7>, R<8>, R<9>, R<10>, R<14>, X, cycloalkyl and W' are as defined in Claim 1. 7. A compound in accordance with Claim 1 represented with the formula: wherein the moiety: is selected from a phenyl, thiophene, furan, pyrrole, or a pyridine ring; R<3> is the moiety of the formula: wherein Ar is selected from the moieties: R<6> is selected from (a) moieties of the formulas: alkyl(C3-C8) straight or branched, alkyl (C3-C8) straight or branched, -NHSO2-alkyl(C3-C8) straight or branched, alkenyl (C3-C8) straight or branched, alkenyl (C3-C8) straight or branched, - NHSO2-alkenyl (C3-C8) straight or branched, wherein cycloalkyl is defined as C3-C6cycloalkyl, cyclohexenyl or cyclopentenyl; Ra is independently selected from hydrogen, -CH3, -C2H5, -(CH2)q-O-alkyl(C1-C3), -CH2CH2OH; q is one or two; Rb is independently selected from hydrogen, -CH3, and -C2H5; (b) a moiety of the formula: wherein J is Ra, alkyl(C3-C8) branched or unbranched, alkenyl(C3-C8) branched or unbranched, O-alkyl(C3-C8) branched or unbranched, -O-alkenyl(C3-C8) branched or unbranched, tetrahydrofuran, tetrahydrothiophene, the moieties: or -CH2-K', wherein K' is (C1-C3)alkoxy, halogen, tetrahydrofuran, tetrahydrothiophene o
申请公布号 EA001143(B1) 申请公布日期 2000.10.30
申请号 EA19970000117 申请日期 1996.01.16
申请人 AMERICAN CYANAMID COMPANY 发明人 ALBRIGHT, JAY, DONALD;VENKATESAN, ARANAPAKAM, MUDUMBAI;DUSZA, JOHN, PAUL;SUM, FUK-WAH
分类号 A61K31/495;A61K31/55;A61P1/16;A61P7/08;A61P9/00;A61P9/12;C07D471/04;C07D471/14;C07D487/04;C07D487/14 主分类号 A61K31/495
代理机构 代理人
主权项
地址